Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective cohort studyResearch in context
Summary: Background: The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is well-tolerated and provides wide protection against SARS-CoV-2 infection. However, the effectiveness of a single-d...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-01-01
|
| Serier: | EClinicalMedicine |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2589537023005515 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
